Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
0.00%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Tectonic Therapeutic, Inc.
Market Cap
$422.86M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$422.72M
Operating Margin
-5.18%
TTM Avg
-142.41%
3Y Avg
-131.34%
5Y Avg
-98.04%
Market Cap
$424.10M
Operating Margin
-8.63%
TTM Avg
-11.52%
3Y Avg
-18.04%
5Y Avg
-16.64%
Market Cap
$419.87M
Operating Margin
-1905.82%
TTM Avg
-1010.09%
3Y Avg
-618.33%
5Y Avg
-2608.93%
Market Cap
$426.51M
Operating Margin
-212.92%
TTM Avg
-108.19%
3Y Avg
-56995.46%
5Y Avg
-38056.30%
Market Cap
$418.95M
Operating Margin
-245.15%
TTM Avg
-511.19%
3Y Avg
-596.30%
5Y Avg
-548.32%
Market Cap
$416.27M
Operating Margin
-193.83%
TTM Avg
-263.44%
3Y Avg
-320.82%
5Y Avg
-550.06%
Market Cap
$431.97M
Operating Margin
-15.26%
TTM Avg
-21.73%
3Y Avg
-43.66%
5Y Avg
-43.15%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tectonic Therapeutic, Inc. (TECX) | $422.86M | 0.00% | 0.00% | 0.00% | 0.00% |
| Tilray Brands, Inc. (TLRY)vs › | $422.72M | -5.18% | -142.41% | -131.34% | -98.04% |
| NeoGenomics, Inc. (NEO)vs › | $424.10M | -8.63% | -11.52% | -18.04% | -16.64% |
| Prothena Corporation plc (PRTA)vs › | $419.87M | -1905.82% | -1010.09% | -618.33% | -2608.93% |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $426.51M | -212.92% | -108.19% | -56995.46% | -38056.30% |
| Editas Medicine, Inc. (EDIT)vs › | $418.95M | -245.15% | -511.19% | -596.30% | -548.32% |
| Senseonics Holdings, Inc. (SENS)vs › | $416.27M | -193.83% | -263.44% | -320.82% | -550.06% |
| Rezolute, Inc. (RZLT)vs › | $415.98M | 0.00% | 0.00% | 0.00% | 0.00% |
| NeuroPace, Inc. (NPCE)vs › | $431.97M | -15.26% | -21.73% | -43.66% | -43.15% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $411.21M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-03-31 | 0.00% |
